From the perspective of China's veterinary drug industry market, under the constant drive of China's animal husbandry and other related industries, the industrial pattern adjustment of China's veterinary drug industry has achieved initial results. Most enterprises actively adjust their production varieties, and pet veterinary drugs have gradually become the key development area of the veterinary drug industry. In addition, under the condition that China has continuously issued laws to regulate the quality of veterinary drugs, the illegal addition of veterinary drugs in the Chinese veterinary drug market has been initially curbed. The number of key monitoring enterprises in the notification of supervision and sampling inspection results has decreased, and the number of illegal added varieties is also decreasing. It is expected that China's veterinary drug industry will usher in a better and safer development in the future. With the rapid development of China's breeding industry, the degree of scale and intensification is constantly improving, and the industry supervision system of veterinary drug industry is also constantly improving. In the long run, the competition for the core R&D ability of future products and technologies is the basis for animal protection enterprises to seize the market. Risks and opportunities coexist. The animal insurance enterprises with strong strength and R&D capability will undoubtedly occupy a larger market share and obtain better development opportunities.

Animal epidemics are an important constraint for China to move from a large livestock and poultry breeding industry to a powerful livestock and poultry breeding industry. The veterinary biological products industry has become an important guarantee for the healthy development of the industry, and is also a key supporting subsidiary of the biomedical industry, one of the seven strategic emerging industries in China. The state has issued a series of industrial policies to continuously improve the construction of animal epidemic prevention system, strengthen the construction of animal epidemic prevention infrastructure, and encourage industrial R&D innovation and large-scale production and application. At present, the domestic breeding industrial structure is undergoing great changes: small farmers are gradually withdrawing, the "company+farmer" breeding model is also being promoted, the market share of large-scale breeding enterprises is gradually increasing, and the scale and intensification of domestic livestock and poultry breeding is constantly improving. Large breeding enterprises pay more attention to disease prevention and control, and have greater demand for high-quality vaccines, which brings good development opportunities for veterinary biological products enterprises, especially leading enterprises in the industry.

With the rapid development of China's breeding industry, the degree of scale and intensification continues to increase, and China's veterinary drug industry has made great progress. In recent years, China's veterinary drug industry has entered the track of steady development. The industry supervision system has been constantly improved, the enterprise scale has been continuously expanded, and the research and development capacity has been constantly improved, which has played an important role in ensuring the healthy and sustainable development of the animal husbandry. "MAE 2023 China (Hunan) Modern Veterinary Medicine Industry Exhibition" will be held in Hunan International Convention and Exhibition Center (Changsha) from April 20 to 21, 2023. With the style of "clear theme, outstanding characteristics, focus on effectiveness and continuous innovation", this exhibition will quickly become famous and influential in the industry. Let the insiders regard it as the best platform to "understand the industry information, grasp the market dynamics, display the enterprise brand, expand trade channels, and seek cooperation opportunities". We pledge to build it into one of the most authoritative, professional and largest professional events in the veterinary drug industry in China.    

1. Veterinary drug products: veterinary drug biological products, veterinary diagnostic reagents, veterinary APIs, veterinary drug preparations, Chinese veterinary drugs, vaccine products and animal health products;

2. Veterinary drug production technology equipment, testing instruments, etc;

3. Veterinary drug packaging materials, raw and auxiliary materials, etc;

4. Animal husbandry and veterinary related products, high-quality breeding livestock and poultry, etc;

• Company:Fargo Exhibition Services (Shanghai) Co., Ltd
• Telephone:021-56570612
• Truename:Mr. li
• Mobile:13361984009
• E-mail:2807841463@qq.com
• Address:No. 471, Sanyi Avenue, Kaifu District, Changsha, Hunan

The information on this site comes from the network and related members, and the website has done its duty to review it. Due to the uncontrollability of the process of organizing the exhibition, some of the exhibition information in the station may change the subject matter, Extending or cancelling the event, please exhibitors and visitors must check with each other again before exhibiting! All the exhibitions in this site are not hosted/co-organized or organized, if there are any disputes during the exhibition, please hold the main responsibility of the exhibition organization! QQ Email: 523138820@qq.com WeChat: 523138820 Mobile: 15313206870